187 related articles for article (PubMed ID: 24156308)
21. Phosphatidylinositol 3 kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation.
Mandal CC; Ghosh Choudhury G; Ghosh-Choudhury N
Endocrinology; 2009 Nov; 150(11):4989-98. PubMed ID: 19819979
[TBL] [Abstract][Full Text] [Related]
22. Corilagin suppresses RANKL-induced osteoclastogenesis and inhibits oestrogen deficiency-induced bone loss via the NF-κB and PI3K/AKT signalling pathways.
Lu J; Ye C; Huang Y; Huang D; Tang L; Hou W; Kuang Z; Chen Y; Xiao S; Yishake M; He R
J Cell Mol Med; 2020 Sep; 24(18):10444-10457. PubMed ID: 32681612
[TBL] [Abstract][Full Text] [Related]
23. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
24. Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss.
Liu C; Guan H; Cai C; Li F; Xiao J
Exp Cell Res; 2017 Mar; 352(2):293-303. PubMed ID: 28209487
[TBL] [Abstract][Full Text] [Related]
25. The flavonoid glabridin attenuates 2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction in MC3T3-E1 osteoblastic cells.
Kim HS; Suh KS; Ko A; Sul D; Choi D; Lee SK; Jung WW
Int J Mol Med; 2013 Jan; 31(1):243-51. PubMed ID: 23128413
[TBL] [Abstract][Full Text] [Related]
26. Anagliptin stimulates osteoblastic cell differentiation and mineralization.
Dong C; Yang H; Wang Y; Yan X; Li D; Cao Z; Ning Y; Zhang C
Biomed Pharmacother; 2020 Sep; 129():109796. PubMed ID: 32559615
[TBL] [Abstract][Full Text] [Related]
27. Network and experimental pharmacology on mechanism of Si-Wu-tang improving ovarian function in a mouse model of premature ovarian failure induced by cyclophosphamide.
Liu X; Song Y; Zhou F; Zhang C; Li F; Hu R; Ma W; Song K; Tang Z; Zhang M
J Ethnopharmacol; 2023 Jan; 301():115842. PubMed ID: 36265674
[TBL] [Abstract][Full Text] [Related]
28. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling.
Li J; Hao L; Wu J; Zhang J; Su J
Int J Mol Med; 2016 Apr; 37(4):901-10. PubMed ID: 26935542
[TBL] [Abstract][Full Text] [Related]
29. l-Quebrachitol Promotes the Proliferation, Differentiation, and Mineralization of MC3T3-E1 Cells: Involvement of the BMP-2/Runx2/MAPK/Wnt/β-Catenin Signaling Pathway.
Yodthong T; Kedjarune-Leggat U; Smythe C; Wititsuwannakul R; Pitakpornpreecha T
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486330
[TBL] [Abstract][Full Text] [Related]
30. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
[TBL] [Abstract][Full Text] [Related]
31. Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats.
Zhou RP; Lin SJ; Wan WB; Zuo HL; Yao FF; Ruan HB; Xu J; Song W; Zhou YC; Wen SY; Dai JH; Zhu ML; Luo J
PLoS One; 2016; 11(12):e0166751. PubMed ID: 28033335
[TBL] [Abstract][Full Text] [Related]
32. Bu-Shen-Ning-Xin decoction: inhibition of osteoclastogenesis by abrogation of the RANKL-induced NFATc1 and NF-κB signaling pathways via selective estrogen receptor α.
Wang L; Qiu XM; Gui YY; Xu YP; Gober HJ; Li DJ
Drug Des Devel Ther; 2015; 9():3755-66. PubMed ID: 26229438
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Neoplastic Transformation and Chemically-Induced Skin Hyperplasia in Mice by Traditional Chinese Medicinal Formula Si-Wu-Tang.
Liu MM; Huang KM; Yeung S; Chang A; Zhang S; Mei N; Parsa C; Orlando R; Huang Y
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28335476
[TBL] [Abstract][Full Text] [Related]
34. BMP9 directly induces rapid GSK3-β phosphorylation in a Wnt-independent manner through class I PI3K-Akt axis in osteoblasts.
Eiraku N; Chiba N; Nakamura T; Amir MS; Seong CH; Ohnishi T; Kusuyama J; Noguchi K; Matsuguchi T
FASEB J; 2019 Nov; 33(11):12124-12134. PubMed ID: 31365832
[TBL] [Abstract][Full Text] [Related]
35. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
[TBL] [Abstract][Full Text] [Related]
36. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
37. The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis.
Xi JC; Zang HY; Guo LX; Xue HB; Liu XD; Bai YB; Ma YZ
J Recept Signal Transduct Res; 2015; 35(6):640-5. PubMed ID: 26390889
[TBL] [Abstract][Full Text] [Related]
38. Cynomorium songaricum prevents bone resorption in ovariectomized rats through RANKL/RANK/TRAF6 mediated suppression of PI3K/AKT and NF-κB pathways.
Ma X; Liu J; Yang L; Zhang B; Dong Y; Zhao Q
Life Sci; 2018 Sep; 209():140-148. PubMed ID: 30092296
[TBL] [Abstract][Full Text] [Related]
39. Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway.
Liu MZ; Zhou DC; Liu Q; Xie FL; Xiang DX; Tang GY; Luo SL
Eur J Pharmacol; 2019 Sep; 858():172480. PubMed ID: 31228453
[TBL] [Abstract][Full Text] [Related]
40. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
